Exact Mass: 647.2438367999999

Exact Mass Matches: 647.2438367999999

Found 41 metabolites which its exact mass value is equals to given mass value 647.2438367999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Deoxydihydrostreptomycin 6-phosphate

3-Deoxydihydrostreptomycin 6-phosphate

C21H42N7O14P (647.2527242)


   

3-Deoxydihydrostreptomycin 3-phosphate

3-Deoxydihydrostreptomycin 3-phosphate

C21H42N7O14P (647.2527242)


   

BGC 945; ONX 0801

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

C32H33N5O10 (647.2227318)


C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor

   

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

2-({4-carboxy-1-hydroxy-4-[(4-{[4-hydroxy-2-(hydroxymethyl)-6H,7H,8H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}phenyl)formamido]butylidene}amino)pentanedioate

C32H33N5O10 (647.2227318)


   

Paulomenol B

Paulomenol B

C28H41NO16 (647.2425226)


   

Di-Ac-Ravidomycin

Di-Ac-Ravidomycin

C35H37NO11 (647.2366492)


   

Asp Asp Asn Arg Glu

Asp Asp Asn Arg Glu

C23H37N9O13 (647.2510712000001)


   

Ala Trp Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Glu Gln Trp Trp

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Glu Trp Gln Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Glu Trp Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H37N7O8 (647.2703482000001)


   

Gln Glu Trp Trp

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Gln Trp Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Gln Trp Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C32H37N7O8 (647.2703482000001)


   

Trp Ala Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Trp Glu Gln Trp

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Trp Glu Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H37N7O8 (647.2703482000001)


   

Trp Gln Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C32H37N7O8 (647.2703482000001)


   

Trp Gln Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C32H37N7O8 (647.2703482000001)


   

Trp Trp Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Trp Trp Glu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-4-carbamoylbutanoic acid

C32H37N7O8 (647.2703482000001)


   

Trp Trp Gln Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]pentanedioic acid

C32H37N7O8 (647.2703482000001)


   

Trp Trp Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C36H37N7O5 (647.2856032)


   

DDNRE

Asp-Asp-Asn-Arg-Glu

C23H37N9O13 (647.2510712000001)


   

Cloperastine fendizoate

Cloperastine fendizoate

C40H38ClNO5 (647.2438367999999)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Lercanidipine hydrochloride

Lercanidipine hydrochloride

C36H42ClN3O6 (647.2761982)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

D-ALA2 D-MET5-ENKEPHALIN ACETATE

D-ALA2 D-MET5-ENKEPHALIN ACETATE

C30H41N5O9S (647.2624856000001)


   

sulfosuccinimidyl n-[n-(d-biotinyl)-6-aminohexanoyl]-6-aminohexanoate

sulfosuccinimidyl n-[n-(d-biotinyl)-6-aminohexanoyl]-6-aminohexanoate

C26H41N5O10S2 (647.2294726000001)


   

(S)-Cloperastine Fendizoate

(S)-Cloperastine Fendizoate

C20H24ClNO.C20H14O4 (647.2438367999999)


   

Dihydro-acarbose

Dihydro-acarbose

C25H45NO18 (647.263651)


   

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

2-({4-carboxy-1-hydroxy-4-[(4-{[4-hydroxy-2-(hydroxymethyl)-6H,7H,8H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}phenyl)formamido]butylidene}amino)pentanedioate

C32H33N5O10 (647.2227318)


   

(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumylheptanedioate

(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumylheptanedioate

C26H41N5O14-2 (647.2649886)


   

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate

C32H45N3O9S-2 (647.287636)


   

Dihydrostreptomycin 3alpha-phosphate

Dihydrostreptomycin 3alpha-phosphate

C21H42N7O14P (647.2527242)


   

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide

C30H37N3O9S2 (647.1971112000001)


   

Protectin conjugate in tissue regeneration 1(2-)

Protectin conjugate in tissue regeneration 1(2-)

C32H45N3O9S-2 (647.287636)


   

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

C32H33N5O10 (647.2227318)


C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor

   

(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-)

(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-)

C32H45N3O9S (647.287636)


A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.

   

16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-)

16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-)

C32H45N3O9S (647.287636)


A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of 16(S)-glutathionyl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid; major species at pH 7.3.

   

5'-O-DMT-N4-Bz-5-Me-dC

5'-O-DMT-N4-Bz-5-Me-dC

C38H37N3O7 (647.2631372000001)


5'-O-DMT-N4-Bz-5-Me-dC is a modified nucleoside. 5'-O-DMT-2'-O-TBDMS-rI can be used in the synthesis of deoxyribonucleic acid or nucleic acid.

   

n-[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C31H37NO14 (647.2213942000001)